Peter Tanuseputro profile picture

Contact Information

Peter Tanuseputro, MD, MHSc, CCFP, FRCPC
X-17343
ptanuseputro@ohri.ca

Publications

Selected Publications

  1. Tanuseputro P, Beach S, Chalifoux M, Wodchis W, Hsu A, Seow H, Manuel D. Associations between physician home visits for the dying and place of death: A population-based retrospective cohort study. PLoS One. 2018 Feb 15;13(2):e0191322.
  2. Tanuseputro P, Budhwani S, Bai YQ, Wodchis W. How much palliative care is delivered at the end-of-life? A population-level observational study in Ontario. Palliative Medicine. 2017 Mar;31(3):247-257.
  3. Tanuseputro P, Chalifoux M, Bennett C, Walker P, Bronskill SE, Gruneir A, Manuel D. Hospitalization and mortality rates in long-term care facilities: Does for-profit status matter? Journal of the American Medical Directors Association (JAMDA). 2015 Oct 1;16(10):874-83.
  4. Tanuseputro P, Wodchis W, Fowler R, Walker P, Bai YQ, Bronskill SE, Manuel DG. The Health Care Cost of Dying: A Retrospective Population-Based Cohort Study of the Last Year of Life. PLoS One. 2015 Mar 26;10(3):e0121759.
  5. Tanuseputro P, Perez R, Rosella L, Wilson K, Bennett C, Tuna M, Hennessy D, Manson H, Manuel D. Improving Global Estimation of the Burden of Risk Factors: How do we really know how many deaths are related to cigarettes? Population Health Metrics 2015 Feb 19;13:5.

  1. Fernando SM, Reardon PM, Dowlatshahi D, English SW, Thavorn K, Tanuseputro P, Perry JJ, Rosenberg E, Wijdicks EF, Heyland DK, Kyeremanteng K. Outcomes and Costs of Patients Admitted to the ICU Due to Spontaneous Intracranial Hemorrhage. Crit Care Med. 2018 Feb 5.
  2. Fernando SM, Reardon PM, Ball IM, van Katwyk S, Thavorn K, Tanuseputro P, Rosenberg E, Kyeremanteng K. Outcomes and Costs of Patients Admitted to the Intensive Care Unit Due to Accidental or Intentional Poisoning. J Intensive Care Med. 2018 Jan 1.
  3. Rice J, Hunter L, Hsu AT, Donskov M, Luciani T, Toal-Sullivan D, Welch V, Tanuseputro P. Using the "Surprise Question" in Nursing Homes: A Prospective Mixed-Methods Study. J Palliat Care. 2018 Jan 1:825859717745728.
  4. Fisher S, Hsu A, Mojaverian N, Taljaard M, Huyer G, Manuel DG, Tanuseputro P. Dementia Population Risk Tool (DemPoRT): study protocol for a predictive algorithm assessing dementia risk in the community. BMJ Open. 2017 Oct 24;7(10)
  5. Yarnell C, Longdib F, Manuel D, Tanuseputro P, Therese S, Scales D, Laupacis A, Fowler R. End-of-life care among recently immigrated versus long-standing residents of Ontario, Canada. JAMA. 2017 Oct 2. doi: 10.1001/jama.2017.14418.
  6. Hsu AT, Tanuseputro P. The Delivery of Palliative and End-of-Life Care in Ontario. Healthc Q. 2017;20(2):6-9.
  7. Chaudhuri D, Tanuseputro P, Herritt B, D'Egidio G, Chalifoux M, Kyeremanteng K., Critical care at the end of life: A population-level retrospective cohort study of cost and outcomes, Critical Care. 2017 May 31;21(1):124.
  8. Murthy S, James P, Antonova L, Chalifoux M, Tanuseputro P. High End of Life Health Care Costs and Hospitalization Burden in Inflammatory Bowel Disease Patients: A Population-Based Study. PLoS One. 2017 May 12;12(5):e0177211.
  9. Tanuseputro P. The author responds to "What matters most". CMAJ. 2017 May 1;189(17):E643.
  10. Tanuseputro P. Delivering care to those in need: Improving palliative care using linked data. Palliat Med. 2017 Jun;31(6):489-491
  11. Tanuseputro P, Hsu A, Kuluski K, Chalifoux M, Donskov M, Beach S, Walker P. Level of Need, Divertibility, and Outcomes of Newly Admitted Nursing Home Residents. J Am Med Dir Assoc (JAMDA). 2017 Apr 1. pii: S1525-8610(17)30103-2.
  12. Kendall C, Chalifoux M, Manuel D, Reinhard R, Robinson G, Bacon J, Rourke S, Rosenes R, Tanuseputro P. A population-based study of care at the end of life among people with HIV in Ontario from 2010 to 2013. J Acquir Immune Defic Syndr (JAIDS). 2017 May 1;75(1):e1-e7.
  13. Widger K, Seow H, Rapoport A, Chalifoux M, Tanuseputro P. Children’s end-of-life health care use and cost: A population-based retrospective-cohort study. Pediatrics. 2017 Mar 2. pii: e20162956. doi: 10.1542/peds.2016-2956.  
  14. Tanuseputro P. Medical Aid in Dying: What matters most? CMAJ January 23, 2017 189:E99-E100.    
  15. Hsu A, Manuel D, Taljaard M, Chalifoux M, Bennett C, Costa A, Bronskill S, Kobewka D, Tanuseputro P.  An algorithm for predicting death among older adults in the home care setting: Study protocol for the Risk Evaluation for Support: Predicting Elder life in the Community Tool (RESPECT). BMJ Open. 2016 Dec 1;6(12):e013666.
  16. Howard M, Chalifoux M, Tanuseputro P. Does primary care model affect health care at the end of life? A population-based retrospective cohort study in Ontario, Canada. Journal of Palliative Medicine. 2016 Nov 28
  17. Batista R, Pottie K, Bouchard L, Ng E, Tanuseputro P, Tugwell P. Primary health care models addressing health equity for immigrants: a systematic scoping review. Journal of Immigrant and Minority Health. 2016 Nov 17.
  18. Manuel D, Perez R, Sanmartin C, Taljaard M, Hennessy D, Wilson K, Tanuseputro P, Manson H, Bennett C, Tuna M, Rosella LC. Preventable causes of death in Canada: assessment of smoking, alcohol, physical activity, and diet using a baseline risk approach. PLoS Med. 2016 Aug 16;13(8):e1002082.
  19. Costa V, Earle CC, Esplen MJ, Fowler R, Goldman R, Grossman D, Levin L, Manuel DG, Sharkey S, Tanuseputro P, You JJ. The determinants of home and nursing home death: a systematic review and meta-analysis. BMC Palliative Care 2016 15:8.
  20. Hennessy DA, Tanuseputro P, Tuna M, Bennett C, Perez R, Shields M, Ko DT, Tu J, Manuel DC. Population health impact of statin treatment in Canada. Health Rep. 2016 Jan 20;27(1):20-28.
  21. Manuel DG, Tuna M, Perez R, Tanuseputro P, Hennessy D, Bennett C, Rosella L, Sanmartin C, van Walraven C, Tu JV. Predicting Stroke Risk Based on Health Behaviours: Development of the Stroke Population Risk Tool (SPoRT). PLoS One. 2015 Dec 4;10(12):e0143342.
  22. Hennessy D, Flanagan W, Tanuseputro P, Bennett C, Tuna M, Kopec J, Wolfson M, Manuel D. The Population Health Model (POHEM): an overview of rationale, methods and applications. Population Health Metrics. 2015 Sep 3;13:24.
  23. Taljaard M, Tuna M, Bennett C, Perez R, Rosella L, Tu J, Sanmartin C, Hennessy D, Tanuseputro P, Lebenbaum M, Manuel D. Cardiovascular Disease Population Risk Tool (CVDPoRT) — predictive algorithm for assessing CVD risk in the community setting: Study protocol. BMJ Open. 2014 Oct 23;4(10):e006701
  24. Pham B, Fowler R, Tanuseputro P, Manuel DG, Sikich N, Baidoobonso S, Pechlivanoglou P, Krahn M. Developing A Population-Based Palliative And End-Of-Life Care Decision-Analytic Policy Model. Value in Health. 2014;17(3):A152-A.
  25. Manuel D, Tuna M, Hennessy D, Bennett C, Okhmatovskaia A, Finés P, Tanuseputro P, Tu J, Flanagan W, Simulation Technology for Applied Research Team and the Canadian Cardiovascular Outcome Research Team. Projections of preventable risks for cardiovascular disease in Canada to 2021: a microsimulation modelling approach. CMAJ Open. 2014 May 20;2(2):E94-E101.
  26. Tanuseputro P, Zagorski B, Chan KJ, Kwong JC. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program. Vaccine. 2011 Nov 3;29(47):8580-4
  27. Kwong JC, Tanuseputro P, Zagorski B, Moineddin R, Chan KJ. Impact of varicella vaccination on health care outcomes in Ontario, Canada: effect of a publicly funded program? Vaccine. 2008 Nov 5;26(47):6006-12.
  28. Manuel DG, Lim J, Tanuseputro P, Stukel Therésè. How many people have had a myocardial infarction? Prevalence estimated using historical hospital data. BMC Public Health. 2007, 7:174.
  29. Manuel DG, Kwong K, Tanuseputro P, Lim J, Mustard CA, Anderson GM, Ardal S, Alter DA, Laupacis A.Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study. British Medical Journal (BMJ). 2006 Jun 17;332(7555):1419.
  30. Xin W, Yin Z, Qin Z, Jian L, Tanuseputro P, Gomez M, Beveridge M, Zhenjiang L.Characteristics of 1494 pediatric burn patients in Shanghai. Burns. 2006 Aug;32(5):613-8.
  31. Manuel DG, Lim J, Tanuseputro P, Anderson GM, Alter DA, Laupacis A, Mustard CA. Revisiting Rose: strategies for reducing coronary heart disease. British Medical Journal (BMJ). 2006 Mar 18;332(7542):659-62
  32. Tanuseputro P, Manuel DG, Schultz SE, Johansen H, Mustard CA. Improving population attributable fraction methods: examining smoking-attributable mortality for 87 geographic regions in Canada. American Journal of Epidemiology 2005 Apr 15;161(8):787-98.
  33. Manuel DG, Tanuseputro P, Mustard CA, Schultz SE, Anderson GM, Ardal S, Alter DA, Laupacis A. The 2003 Canadian recommendations for dyslipidemia management: revisions are needed. CMAJ. 2005 Apr 12;172(8):1027-31.
  34. Tanuseputro P, Manuel DG and Schultz S. Estimating smoking-attributable mortality. Canadian Journal of Public Health. 2004; 95(2):132. Letter.
  35. Tanuseputro P, Manuel DG, Leung M, Nguyen K and Johansen H. Risk factors for cardiovascular disease in Canada. Canadian Journal of Cardiology 2003; 19(11):1249-1259.
  36. Manuel DG, Leung M, Nguyen K, Tanuseputro P and Johansen H. Burden of cardiovascular disease in Canada. Canadian Journal of Cardiology 2003; 19(9):997-1004.

PubMed Listings

For more publications use this PubMed ID link.